ASCL1 and neuroblastoma: Additional activation by preventing the CDK-dependent phosphorylation of ASCL1 further engages an extensive programme of cell cycle exit and terminal differentiation (Ali et al., 2014; Ali et al., 2020), indicating that the level of ASCL1 is critical to determining the balance between proliferation and differentiation in neuroblastoma.